COVID-19 Outbreak-Global Active Pharmaceutical Ingredient Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- MAI4056500
- 104 Pages
- September 2020
- BFSI
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Active Pharmaceutical Ingredient industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Active Pharmaceutical Ingredient market can be split based on product types, major applications, and important countries as follows:
Key players in the global Active Pharmaceutical Ingredient market covered in Chapter 12:
Jiangsu Hengrui Medicine
Dr. Reddy's Laboratories
Shandong Lukang Pharmaceutical
Roche
Tian Yao
Lupin
Biocon
Aurobindo pharma
Novartis
BASF
Lonza group
Albemarle
North China Pharmaceutical Group
Shandong Xinhua Pharmaceutical
DSM
Huahai Pharmaceutical
North East Pharmaceutical
Zhejiang Medicine
Boehringer Ingelheim GmbH
Mylan
Cipla
Sun Pharmaceutical Industries
Teva
Cambrex
Bayer
Johnson & Johnson
Johnson Matthey
Bachem
Hisun Pharmacy
Pfizer
Haerbin Pharmaceutical Group
In Chapter 4 and 14.1, on the basis of types, the Active Pharmaceutical Ingredient market from 2015 to 2025 is primarily split into:
Biotech API
Synthetic API
Others
In Chapter 5 and 14.2, on the basis of applications, the Active Pharmaceutical Ingredient market from 2015 to 2025 covers:
Anti-diabetic Drugs
Oncology Drugs
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 Active Pharmaceutical Ingredient Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Active Pharmaceutical Ingredient
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Active Pharmaceutical Ingredient industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Active Pharmaceutical Ingredient Market Size, 2015 – 2020
2.1.2 Global Active Pharmaceutical Ingredient Market Size by Type, 2015 – 2020
2.1.3 Global Active Pharmaceutical Ingredient Market Size by Application, 2015 – 2020
2.1.4 Global Active Pharmaceutical Ingredient Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Active Pharmaceutical Ingredient Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Active Pharmaceutical Ingredient Analysis
3.2 Major Players of Active Pharmaceutical Ingredient
3.3 Active Pharmaceutical Ingredient Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Active Pharmaceutical Ingredient
3.3.3 Labor Cost of Active Pharmaceutical Ingredient
3.4 Market Distributors of Active Pharmaceutical Ingredient
3.5 Major Downstream Buyers of Active Pharmaceutical Ingredient Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Active Pharmaceutical Ingredient Market, by Type
4.1 Global Active Pharmaceutical Ingredient Value and Market Share by Type (2015-2020)
4.2 Global Active Pharmaceutical Ingredient Production and Market Share by Type (2015-2020)
4.3 Global Active Pharmaceutical Ingredient Value and Growth Rate by Type (2015-2020)
4.3.1 Global Active Pharmaceutical Ingredient Value and Growth Rate of Biotech API
4.3.2 Global Active Pharmaceutical Ingredient Value and Growth Rate of Synthetic API
4.3.3 Global Active Pharmaceutical Ingredient Value and Growth Rate of Others
4.4 Global Active Pharmaceutical Ingredient Price Analysis by Type (2015-2020)
5 Active Pharmaceutical Ingredient Market, by Application
5.1 Downstream Market Overview
5.2 Global Active Pharmaceutical Ingredient Consumption and Market Share by Application (2015-2020)
5.3 Global Active Pharmaceutical Ingredient Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Active Pharmaceutical Ingredient Consumption and Growth Rate of Anti-diabetic Drugs (2015-2020)
5.3.2 Global Active Pharmaceutical Ingredient Consumption and Growth Rate of Oncology Drugs (2015-2020)
5.3.3 Global Active Pharmaceutical Ingredient Consumption and Growth Rate of Non-steroidal Anti-inflammatory Drugs (NSAIDs) (2015-2020)
6 Global Active Pharmaceutical Ingredient Market Analysis by Regions
6.1 Global Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Regions
6.1.1 Global Active Pharmaceutical Ingredient Sales by Regions (2015-2020)
6.1.2 Global Active Pharmaceutical Ingredient Revenue by Regions (2015-2020)
6.2 North America Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.3 Europe Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.6 South America Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7 North America Active Pharmaceutical Ingredient Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Countries
7.2.1 North America Active Pharmaceutical Ingredient Sales by Countries (2015-2020)
7.2.2 North America Active Pharmaceutical Ingredient Revenue by Countries (2015-2020)
7.3 United States Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.4 Canada Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.5 Mexico Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8 Europe Active Pharmaceutical Ingredient Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Countries
8.2.1 Europe Active Pharmaceutical Ingredient Sales by Countries (2015-2020)
8.2.2 Europe Active Pharmaceutical Ingredient Revenue by Countries (2015-2020)
8.3 Germany Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8.4 UK Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8.5 France Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8.6 Italy Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8.7 Spain Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8.8 Russia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9 Asia Pacific Active Pharmaceutical Ingredient Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Active Pharmaceutical Ingredient Sales by Countries (2015-2020)
9.2.2 Asia Pacific Active Pharmaceutical Ingredient Revenue by Countries (2015-2020)
9.3 China Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.4 Japan Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.5 South Korea Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.6 India Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.8 Australia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
10 Middle East and Africa Active Pharmaceutical Ingredient Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Active Pharmaceutical Ingredient Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Active Pharmaceutical Ingredient Revenue by Countries (2015-2020)
10.3 Saudi Arabia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
10.4 UAE Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
10.5 Egypt Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
10.6 Nigeria Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
10.7 South Africa Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
11 South America Active Pharmaceutical Ingredient Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Countries
11.2.1 South America Active Pharmaceutical Ingredient Sales by Countries (2015-2020)
11.2.2 South America Active Pharmaceutical Ingredient Revenue by Countries (2015-2020)
11.3 Brazil Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
11.4 Argentina Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
11.5 Columbia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
11.6 Chile Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Jiangsu Hengrui Medicine
12.1.1 Jiangsu Hengrui Medicine Basic Information
12.1.2 Active Pharmaceutical Ingredient Product Introduction
12.1.3 Jiangsu Hengrui Medicine Production, Value, Price, Gross Margin 2015-2020
12.2 Dr. Reddy's Laboratories
12.2.1 Dr. Reddy's Laboratories Basic Information
12.2.2 Active Pharmaceutical Ingredient Product Introduction
12.2.3 Dr. Reddy's Laboratories Production, Value, Price, Gross Margin 2015-2020
12.3 Shandong Lukang Pharmaceutical
12.3.1 Shandong Lukang Pharmaceutical Basic Information
12.3.2 Active Pharmaceutical Ingredient Product Introduction
12.3.3 Shandong Lukang Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
12.4 Roche
12.4.1 Roche Basic Information
12.4.2 Active Pharmaceutical Ingredient Product Introduction
12.4.3 Roche Production, Value, Price, Gross Margin 2015-2020
12.5 Tian Yao
12.5.1 Tian Yao Basic Information
12.5.2 Active Pharmaceutical Ingredient Product Introduction
12.5.3 Tian Yao Production, Value, Price, Gross Margin 2015-2020
12.6 Lupin
12.6.1 Lupin Basic Information
12.6.2 Active Pharmaceutical Ingredient Product Introduction
12.6.3 Lupin Production, Value, Price, Gross Margin 2015-2020
12.7 Biocon
12.7.1 Biocon Basic Information
12.7.2 Active Pharmaceutical Ingredient Product Introduction
12.7.3 Biocon Production, Value, Price, Gross Margin 2015-2020
12.8 Aurobindo pharma
12.8.1 Aurobindo pharma Basic Information
12.8.2 Active Pharmaceutical Ingredient Product Introduction
12.8.3 Aurobindo pharma Production, Value, Price, Gross Margin 2015-2020
12.9 Novartis
12.9.1 Novartis Basic Information
12.9.2 Active Pharmaceutical Ingredient Product Introduction
12.9.3 Novartis Production, Value, Price, Gross Margin 2015-2020
12.10 BASF
12.10.1 BASF Basic Information
12.10.2 Active Pharmaceutical Ingredient Product Introduction
12.10.3 BASF Production, Value, Price, Gross Margin 2015-2020
12.11 Lonza group
12.11.1 Lonza group Basic Information
12.11.2 Active Pharmaceutical Ingredient Product Introduction
12.11.3 Lonza group Production, Value, Price, Gross Margin 2015-2020
12.12 Albemarle
12.12.1 Albemarle Basic Information
12.12.2 Active Pharmaceutical Ingredient Product Introduction
12.12.3 Albemarle Production, Value, Price, Gross Margin 2015-2020
12.13 North China Pharmaceutical Group
12.13.1 North China Pharmaceutical Group Basic Information
12.13.2 Active Pharmaceutical Ingredient Product Introduction
12.13.3 North China Pharmaceutical Group Production, Value, Price, Gross Margin 2015-2020
12.14 Shandong Xinhua Pharmaceutical
12.14.1 Shandong Xinhua Pharmaceutical Basic Information
12.14.2 Active Pharmaceutical Ingredient Product Introduction
12.14.3 Shandong Xinhua Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
12.15 DSM
12.15.1 DSM Basic Information
12.15.2 Active Pharmaceutical Ingredient Product Introduction
12.15.3 DSM Production, Value, Price, Gross Margin 2015-2020
12.16 Huahai Pharmaceutical
12.16.1 Huahai Pharmaceutical Basic Information
12.16.2 Active Pharmaceutical Ingredient Product Introduction
12.16.3 Huahai Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
12.17 North East Pharmaceutical
12.17.1 North East Pharmaceutical Basic Information
12.17.2 Active Pharmaceutical Ingredient Product Introduction
12.17.3 North East Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
12.18 Zhejiang Medicine
12.18.1 Zhejiang Medicine Basic Information
12.18.2 Active Pharmaceutical Ingredient Product Introduction
12.18.3 Zhejiang Medicine Production, Value, Price, Gross Margin 2015-2020
12.19 Boehringer Ingelheim GmbH
12.19.1 Boehringer Ingelheim GmbH Basic Information
12.19.2 Active Pharmaceutical Ingredient Product Introduction
12.19.3 Boehringer Ingelheim GmbH Production, Value, Price, Gross Margin 2015-2020
12.20 Mylan
12.20.1 Mylan Basic Information
12.20.2 Active Pharmaceutical Ingredient Product Introduction
12.20.3 Mylan Production, Value, Price, Gross Margin 2015-2020
12.21 Cipla
12.21.1 Cipla Basic Information
12.21.2 Active Pharmaceutical Ingredient Product Introduction
12.21.3 Cipla Production, Value, Price, Gross Margin 2015-2020
12.22 Sun Pharmaceutical Industries
12.22.1 Sun Pharmaceutical Industries Basic Information
12.22.2 Active Pharmaceutical Ingredient Product Introduction
12.22.3 Sun Pharmaceutical Industries Production, Value, Price, Gross Margin 2015-2020
12.23 Teva
12.23.1 Teva Basic Information
12.23.2 Active Pharmaceutical Ingredient Product Introduction
12.23.3 Teva Production, Value, Price, Gross Margin 2015-2020
12.24 Cambrex
12.24.1 Cambrex Basic Information
12.24.2 Active Pharmaceutical Ingredient Product Introduction
12.24.3 Cambrex Production, Value, Price, Gross Margin 2015-2020
12.25 Bayer
12.25.1 Bayer Basic Information
12.25.2 Active Pharmaceutical Ingredient Product Introduction
12.25.3 Bayer Production, Value, Price, Gross Margin 2015-2020
12.26 Johnson & Johnson
12.26.1 Johnson & Johnson Basic Information
12.26.2 Active Pharmaceutical Ingredient Product Introduction
12.26.3 Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
12.27 Johnson Matthey
12.27.1 Johnson Matthey Basic Information
12.27.2 Active Pharmaceutical Ingredient Product Introduction
12.27.3 Johnson Matthey Production, Value, Price, Gross Margin 2015-2020
12.28 Bachem
12.28.1 Bachem Basic Information
12.28.2 Active Pharmaceutical Ingredient Product Introduction
12.28.3 Bachem Production, Value, Price, Gross Margin 2015-2020
12.29 Hisun Pharmacy
12.29.1 Hisun Pharmacy Basic Information
12.29.2 Active Pharmaceutical Ingredient Product Introduction
12.29.3 Hisun Pharmacy Production, Value, Price, Gross Margin 2015-2020
12.30 Pfizer
12.30.1 Pfizer Basic Information
12.30.2 Active Pharmaceutical Ingredient Product Introduction
12.30.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
12.31 Haerbin Pharmaceutical Group
12.31.1 Haerbin Pharmaceutical Group Basic Information
12.31.2 Active Pharmaceutical Ingredient Product Introduction
12.31.3 Haerbin Pharmaceutical Group Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Active Pharmaceutical Ingredient Market Forecast
14.1 Global Active Pharmaceutical Ingredient Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Biotech API Market Value and Volume Forecast (2020-2025)
14.1.2 Synthetic API Market Value and Volume Forecast (2020-2025)
14.1.3 Others Market Value and Volume Forecast (2020-2025)
14.2 Global Active Pharmaceutical Ingredient Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Anti-diabetic Drugs Market Value and Volume Forecast (2020-2025)
14.2.2 Oncology Drugs Market Value and Volume Forecast (2020-2025)
14.2.3 Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Value and Volume Forecast (2020-2025)
14.3 Active Pharmaceutical Ingredient Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Active Pharmaceutical Ingredient
Table Product Specification of Active Pharmaceutical Ingredient
Table Active Pharmaceutical Ingredient Key Market Segments
Table Key Players Active Pharmaceutical Ingredient Covered
Figure Global Active Pharmaceutical Ingredient Market Size, 2015 – 2025
Table Different Types of Active Pharmaceutical Ingredient
Figure Global Active Pharmaceutical Ingredient Value ($) Segment by Type from 2015-2020
Figure Global Active Pharmaceutical Ingredient Market Share by Types in 2019
Table Different Applications of Active Pharmaceutical Ingredient
Figure Global Active Pharmaceutical Ingredient Value ($) Segment by Applications from 2015-2020
Figure Global Active Pharmaceutical Ingredient Market Share by Applications in 2019
Figure Global Active Pharmaceutical Ingredient Market Share by Regions in 2019
Figure North America Active Pharmaceutical Ingredient Production Value ($) and Growth Rate (2015-2020)
Figure Europe Active Pharmaceutical Ingredient Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Active Pharmaceutical Ingredient Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Active Pharmaceutical Ingredient Production Value ($) and Growth Rate (2015-2020)
Figure South America Active Pharmaceutical Ingredient Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Active Pharmaceutical Ingredient
Table Upstream Raw Material Suppliers of Active Pharmaceutical Ingredient with Contact Information
Table Major Players Headquarters, and Service Area of Active Pharmaceutical Ingredient
Figure Major Players Production Value Market Share of Active Pharmaceutical Ingredient in 2019
Table Major Players Active Pharmaceutical Ingredient Product Types in 2019
Figure Production Process of Active Pharmaceutical Ingredient
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredient
Figure Channel Status of Active Pharmaceutical Ingredient
Table Major Distributors of Active Pharmaceutical Ingredient with Contact Information
Table Major Downstream Buyers of Active Pharmaceutical Ingredient with Contact Information
Table Global Active Pharmaceutical Ingredient Value ($) by Type (2015-2020)
Table Global Active Pharmaceutical Ingredient Value Share by Type (2015-2020)
Figure Global Active Pharmaceutical Ingredient Value Share by Type (2015-2020)
Table Global Active Pharmaceutical Ingredient Production by Type (2015-2020)
Table Global Active Pharmaceutical Ingredient Production Share by Type (2015-2020)
Figure Global Active Pharmaceutical Ingredient Production Share by Type (2015-2020)
Figure Global Active Pharmaceutical Ingredient Value ($) and Growth Rate of Biotech API (2015-2020)
Figure Global Active Pharmaceutical Ingredient Value ($) and Growth Rate of Synthetic API (2015-2020)
Figure Global Active Pharmaceutical Ingredient Value ($) and Growth Rate of Others (2015-2020)
Figure Global Active Pharmaceutical Ingredient Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Active Pharmaceutical Ingredient Consumption by Application (2015-2020)
Table Global Active Pharmaceutical Ingredient Consumption Market Share by Application (2015-2020)
Figure Global Active Pharmaceutical Ingredient Consumption Market Share by Application (2015-2020)
Figure Global Active Pharmaceutical Ingredient Consumption and Growth Rate of Anti-diabetic Drugs (2015-2020)
Figure Global Active Pharmaceutical Ingredient Consumption and Growth Rate of Oncology Drugs (2015-2020)
Figure Global Active Pharmaceutical Ingredient Consumption and Growth Rate of Non-steroidal Anti-inflammatory Drugs (NSAIDs) (2015-2020)
Figure Global Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure Global Active Pharmaceutical Ingredient Revenue (M USD) and Growth (2015-2020)
Table Global Active Pharmaceutical Ingredient Sales by Regions (2015-2020)
Table Global Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)
Table Global Active Pharmaceutical Ingredient Revenue (M USD) by Regions (2015-2020)
Table Global Active Pharmaceutical Ingredient Revenue Market Share by Regions (2015-2020)
Table Global Active Pharmaceutical Ingredient Revenue Market Share by Regions in 2015
Table Global Active Pharmaceutical Ingredient Revenue Market Share by Regions in 2019
Figure North America Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure Europe Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure South America Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Active Pharmaceutical Ingredient Revenue (M USD) and Growth (2015-2020)
Table North America Active Pharmaceutical Ingredient Sales by Countries (2015-2020)
Table North America Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table North America Active Pharmaceutical Ingredient Revenue (M USD) by Countries (2015-2020)
Table North America Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Figure United States Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure Canada Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure Mexico Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Active Pharmaceutical Ingredient Revenue (M USD) and Growth (2015-2020)
Table Europe Active Pharmaceutical Ingredient Sales by Countries (2015-2020)
Table Europe Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table Europe Active Pharmaceutical Ingredient Revenue (M USD) by Countries (2015-2020)
Table Europe Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Figure Germany Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure UK Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure France Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure Italy Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure Spain Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure Russia Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Active Pharmaceutical Ingredient Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Active Pharmaceutical Ingredient Sales by Countries (2015-2020)
Table Asia Pacific Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table Asia Pacific Active Pharmaceutical Ingredient Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Figure China Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure Japan Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure South Korea Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure India Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure Southeast Asia Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure Australia Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure Middle East Active Pharmaceutical Ingredient Revenue (M USD) and Growth (2015-2020)
Table Middle East Active Pharmaceutical Ingredient Sales by Countries (2015-2020)
Table Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Active Pharmaceutical Ingredient Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure UAE Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure Egypt Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure Nigeria Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure South Africa Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure South America Active Pharmaceutical Ingredient Revenue (M USD) and Growth (2015-2020)
Table South America Active Pharmaceutical Ingredient Sales by Countries (2015-2020)
Table South America Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table South America Active Pharmaceutical Ingredient Revenue (M USD) by Countries (2015-2020)
Table South America Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Figure Brazil Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure Argentina Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure Columbia Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure Chile Active Pharmaceutical Ingredient Sales and Growth (2015-2020)
Figure Top 3 Market Share of Active Pharmaceutical Ingredient Companies in 2019
Figure Top 6 Market Share of Active Pharmaceutical Ingredient Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Jiangsu Hengrui Medicine Profile
Table Jiangsu Hengrui Medicine Product Introduction
Figure Jiangsu Hengrui Medicine Production and Growth Rate
Figure Jiangsu Hengrui Medicine Value ($) Market Share 2015-2020
Table Dr. Reddy's Laboratories Profile
Table Dr. Reddy's Laboratories Product Introduction
Figure Dr. Reddy's Laboratories Production and Growth Rate
Figure Dr. Reddy's Laboratories Value ($) Market Share 2015-2020
Table Shandong Lukang Pharmaceutical Profile
Table Shandong Lukang Pharmaceutical Product Introduction
Figure Shandong Lukang Pharmaceutical Production and Growth Rate
Figure Shandong Lukang Pharmaceutical Value ($) Market Share 2015-2020
Table Roche Profile
Table Roche Product Introduction
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2015-2020
Table Tian Yao Profile
Table Tian Yao Product Introduction
Figure Tian Yao Production and Growth Rate
Figure Tian Yao Value ($) Market Share 2015-2020
Table Lupin Profile
Table Lupin Product Introduction
Figure Lupin Production and Growth Rate
Figure Lupin Value ($) Market Share 2015-2020
Table Biocon Profile
Table Biocon Product Introduction
Figure Biocon Production and Growth Rate
Figure Biocon Value ($) Market Share 2015-2020
Table Aurobindo pharma Profile
Table Aurobindo pharma Product Introduction
Figure Aurobindo pharma Production and Growth Rate
Figure Aurobindo pharma Value ($) Market Share 2015-2020
Table Novartis Profile
Table Novartis Product Introduction
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2015-2020
Table BASF Profile
Table BASF Product Introduction
Figure BASF Production and Growth Rate
Figure BASF Value ($) Market Share 2015-2020
Table Lonza group Profile
Table Lonza group Product Introduction
Figure Lonza group Production and Growth Rate
Figure Lonza group Value ($) Market Share 2015-2020
Table Albemarle Profile
Table Albemarle Product Introduction
Figure Albemarle Production and Growth Rate
Figure Albemarle Value ($) Market Share 2015-2020
Table North China Pharmaceutical Group Profile
Table North China Pharmaceutical Group Product Introduction
Figure North China Pharmaceutical Group Production and Growth Rate
Figure North China Pharmaceutical Group Value ($) Market Share 2015-2020
Table Shandong Xinhua Pharmaceutical Profile
Table Shandong Xinhua Pharmaceutical Product Introduction
Figure Shandong Xinhua Pharmaceutical Production and Growth Rate
Figure Shandong Xinhua Pharmaceutical Value ($) Market Share 2015-2020
Table DSM Profile
Table DSM Product Introduction
Figure DSM Production and Growth Rate
Figure DSM Value ($) Market Share 2015-2020
Table Huahai Pharmaceutical Profile
Table Huahai Pharmaceutical Product Introduction
Figure Huahai Pharmaceutical Production and Growth Rate
Figure Huahai Pharmaceutical Value ($) Market Share 2015-2020
Table North East Pharmaceutical Profile
Table North East Pharmaceutical Product Introduction
Figure North East Pharmaceutical Production and Growth Rate
Figure North East Pharmaceutical Value ($) Market Share 2015-2020
Table Zhejiang Medicine Profile
Table Zhejiang Medicine Product Introduction
Figure Zhejiang Medicine Production and Growth Rate
Figure Zhejiang Medicine Value ($) Market Share 2015-2020
Table Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Product Introduction
Figure Boehringer Ingelheim GmbH Production and Growth Rate
Figure Boehringer Ingelheim GmbH Value ($) Market Share 2015-2020
Table Mylan Profile
Table Mylan Product Introduction
Figure Mylan Production and Growth Rate
Figure Mylan Value ($) Market Share 2015-2020
Table Cipla Profile
Table Cipla Product Introduction
Figure Cipla Production and Growth Rate
Figure Cipla Value ($) Market Share 2015-2020
Table Sun Pharmaceutical Industries Profile
Table Sun Pharmaceutical Industries Product Introduction
Figure Sun Pharmaceutical Industries Production and Growth Rate
Figure Sun Pharmaceutical Industries Value ($) Market Share 2015-2020
Table Teva Profile
Table Teva Product Introduction
Figure Teva Production and Growth Rate
Figure Teva Value ($) Market Share 2015-2020
Table Cambrex Profile
Table Cambrex Product Introduction
Figure Cambrex Production and Growth Rate
Figure Cambrex Value ($) Market Share 2015-2020
Table Bayer Profile
Table Bayer Product Introduction
Figure Bayer Production and Growth Rate
Figure Bayer Value ($) Market Share 2015-2020
Table Johnson & Johnson Profile
Table Johnson & Johnson Product Introduction
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2015-2020
Table Johnson Matthey Profile
Table Johnson Matthey Product Introduction
Figure Johnson Matthey Production and Growth Rate
Figure Johnson Matthey Value ($) Market Share 2015-2020
Table Bachem Profile
Table Bachem Product Introduction
Figure Bachem Production and Growth Rate
Figure Bachem Value ($) Market Share 2015-2020
Table Hisun Pharmacy Profile
Table Hisun Pharmacy Product Introduction
Figure Hisun Pharmacy Production and Growth Rate
Figure Hisun Pharmacy Value ($) Market Share 2015-2020
Table Pfizer Profile
Table Pfizer Product Introduction
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table Haerbin Pharmaceutical Group Profile
Table Haerbin Pharmaceutical Group Product Introduction
Figure Haerbin Pharmaceutical Group Production and Growth Rate
Figure Haerbin Pharmaceutical Group Value ($) Market Share 2015-2020
Table Market Driving Factors of Active Pharmaceutical Ingredient
Table Merger, Acquisition and New Investment
Table Global Active Pharmaceutical Ingredient Market Value ($) Forecast, by Type
Table Global Active Pharmaceutical Ingredient Market Volume Forecast, by Type
Figure Global Active Pharmaceutical Ingredient Market Value ($) and Growth Rate Forecast of Biotech API (2020-2025)
Figure Global Active Pharmaceutical Ingredient Market Volume ($) and Growth Rate Forecast of Biotech API (2020-2025)
Figure Global Active Pharmaceutical Ingredient Market Value ($) and Growth Rate Forecast of Synthetic API (2020-2025)
Figure Global Active Pharmaceutical Ingredient Market Volume ($) and Growth Rate Forecast of Synthetic API (2020-2025)
Similar Reports
Online banking or internet banking is a service provided by retail bank, virtual bank (neo banks) or credit unions. Online banking provides the customers with a secure website through which they can conduct financial transactions. Recent trends show that, customers are keenly adopting on...
- Publish Date: July 31, 2017
- $5370
ATMs have evolved from just cash dispensing machines to multifunctional equipment that provide not only cash withdrawal facilities but offer currency conversions facilities, account information, deposits, transfers, bill payment, cash recycling among other services. The Asia-Pacific region is becoming increasingly characterized by technology-facilitated transactions. ...
- Publish Date: March 1, 2016
- $3390
The Global P2P Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the P2P industry. The report provides a basic overview of the industry including definitions and classifications. The P2P market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. ...
- Publish Date: January 15, 2016
- $2800
